These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16650772)

  • 61. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
    Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
    Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characterization of mutations in the VP(1) region of Sabin strain type 1 polioviruses isolated from vaccine-associated paralytic poliomyelitis cases in Iran.
    Rahimi P; Tabatabaie H; Gouya MM; Zahraie M; Mahmudi M; Ziaie A; Rad KS; Shahmahmudi Sh; Musavi T; Azad TM; Nategh R
    J Clin Virol; 2007 Aug; 39(4):304-7. PubMed ID: 17590391
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Poliomyelitis surveillance in the Czech Republic from the start of vaccination to the certification of eradication in the European Region].
    Matyásová I
    Epidemiol Mikrobiol Imunol; 2005 Feb; 54(1):16-20. PubMed ID: 15807383
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Progress toward poliomyelitis eradication--India, January 2006-September 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Nov; 56(45):1187-91. PubMed ID: 18004237
    [TBL] [Abstract][Full Text] [Related]  

  • 65. World wide experience with inactivated poliovirus vaccine.
    Bonnet MC; Dutta A
    Vaccine; 2008 Sep; 26(39):4978-83. PubMed ID: 18680777
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Progress toward poliomyelitis eradication--Nigeria, January 2008-July 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(41):1150-4. PubMed ID: 19847150
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man.
    MacLennan C; Dunn G; Huissoon AP; Kumararatne DS; Martin J; O'Leary P; Thompson RA; Osman H; Wood P; Minor P; Wood DJ; Pillay D
    Lancet; 2004 May; 363(9420):1509-13. PubMed ID: 15135598
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Use of oral polio vaccine for polio eradication.
    Bhatnagar P; Bahl S; Biswal P
    J Indian Med Assoc; 2005 Dec; 103(12):680-1. PubMed ID: 16821664
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Wild polio virus surveillance in the sewage system of selected communities at the risk of poliomyelitis in southwest Nigeria.
    Adu FD; Kembi FA; Bamgboye A; Osei-Kwasi M
    East Afr Med J; 1998 Feb; 75(2):97-9. PubMed ID: 9640832
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Detecting polio through surveillance for acute flaccid paralysis (AFP).
    Deshpande J; Ram M; Durrani S; Wenger J
    J Indian Med Assoc; 2005 Dec; 103(12):671-5. PubMed ID: 16821661
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.
    Yang C; Shi H; Zhou J; Liang Y; Xu H
    Vaccine; 2009 Nov; 27(47):6558-63. PubMed ID: 19729087
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Non-polio enteroviruses in acute flaccid paralysis children of India: vital assessment before polio eradication.
    Dhole TN; Ayyagari A; Chowdhary R; Shakya AK; Shrivastav N; Datta T; Prakash V
    J Paediatr Child Health; 2009; 45(7-8):409-13. PubMed ID: 19712176
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Surveillance of poliomyelitis in Italy: immunity status of population against polio and environmental circulation of Poliovirus. General illustration of the results.
    Patti AM; Santi AL; Vulcano A; Casagni L; Lamberti A; De Stefano Caraffa D; Vellucci L; Fiore L; Fara GM
    Ann Ig; 2002; 14(4 Suppl 5):1-57. PubMed ID: 12389292
    [No Abstract]   [Full Text] [Related]  

  • 74. Three cases of paralytic poliomyelitis associated with type 3 vaccine poliovirus strains in Bulgaria.
    Korsun N; Kojouharova M; Vladimirova N; Fiore L; Litvinenko I; Buttinelli G; Fiore S; Voynova-Georgieva V; Mladenova Z; Georgieva D
    J Med Virol; 2009 Sep; 81(9):1661-7. PubMed ID: 19626606
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Surveillance for polioviruses.
    Hovi T
    Biologicals; 2006 Jun; 34(2):123-6. PubMed ID: 16678443
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Eradicating polio: it's feasibility in near future?
    Singh P; Das JK; Dutta PK
    J Commun Dis; 2008 Dec; 40(4):225-32. PubMed ID: 19579713
    [TBL] [Abstract][Full Text] [Related]  

  • 77. New Strains Intended for the Production of Inactivated Polio Vaccine at Low-Containment After Eradication.
    Knowlson S; Burlison J; Giles E; Fox H; Macadam AJ; Minor PD
    PLoS Pathog; 2015 Dec; 11(12):e1005316. PubMed ID: 26720150
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Review of the studies on primary immunodeficiency disorder and vaccine-derived poliovirus].
    Xia W; Li L
    Zhongguo Yi Miao He Mian Yi; 2010 Jun; 16(3):279-82, 292. PubMed ID: 20726276
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Use of mutational pattern in 5'-NCR and VP1 regions of polioviruses for molecular diagnosis.
    Pliaka V; Dedepsidis E; Kyriakopoulou Z; Papadopoulou I; Levidiotou S; Markoulatos P
    Mol Cell Probes; 2007 Aug; 21(4):267-75. PubMed ID: 17336496
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The pathogenesis of poliomyelitis: what we don't know.
    Nathanson N
    Adv Virus Res; 2008; 71():1-50. PubMed ID: 18585526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.